New strategy aims to outsmart dangerous Post-Transplant virus
NCT ID NCT07443501
Summary
This study is testing a personalized scoring system to help doctors decide the safest time to stop preventive antiviral medication after a stem cell transplant. It aims to reduce the risk of a common and serious viral infection called CMV while avoiding the side effects of taking the drug for too long. The study will involve over 1,100 adult transplant patients in China.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CMV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.